Abstract:To cope with novel virus infections to which no prior adaptive immunity exists, the body strongly relies on the innate immune system. In such cases, including infections with SARS-CoV-2, children tend to fair better than adults. In the context of COVID-19, it became evident that a rapid interferon response at the site of primary infection is key for successful control of the virus and prevention of severe disease. The airway epithelium of children was shown to exhibit a primed state already at homeostasis and to respond particularly well to SARS-CoV-2 infection. However, the underlying mechanism for this priming remained elusive. Here we show that interactions between airway mucosal immune cells and epithelial cells are stronger in children, and via cytokine-mediated signaling lead to IRF-1-dependent upregulation of the viral sensors RIG-I and MDA5. Based on a cellular in vitro model we show that stimulated human peripheral blood mononuclear cells (PBMC) can induce a robust interferon-beta response towards SARS-CoV-2 in a lung epithelial cell line otherwise unresponsive to this virus. This is mediated by type I interferon, interferon-gamma and TNF, and requires induction of both, RIG-I and MDA5. In single cell-analysis of nasal swab samples the same cytokines are found to be elevated in mucosal immune cells of children, correlating with elevated epithelial expression of viral sensors. In vitro analysis of PBMC derived from healthy adolescents and adults confirm that immune cells of younger individuals show increased cytokine production and potential to prime epithelial cells. In co-culture with SARS-CoV-2-infected A549 cells, PBMC from adolescents significantly enhance the antiviral response. Taken together, our study suggests that higher numbers and a more vigorous activity of innate immune cells in the airway mucosa of children tune the set-point of the epithelial antiviral system. This likely is a major contributor to the robust immune response to SARS-CoV-2 in children. Our findings shed light on the molecular underpinnings of the stunning resilience of children towards severe COVID-19, and may propose a novel concept for immunoprophylactic treatments.

Primary SARS‐CoV‐2 infection in children and adults results in similar Fc‐mediated antibody effector function patterns

Differences In Clinical Features And Laboratory Results Between Adults And Children With Sars-Cov-2 Infection

Difference in respiratory syncytial virus-specific Fc-mediated antibody effector functions between children and adults

The kinetics and durability of antibody and T-cell responses to SARS-CoV-2 in children

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection

The Effect of Age and Comorbidities: Children vs. Adults in Their Response to SARS-CoV-2 Infection

Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children

Systems serology detects functionally distinct coronavirus antibody features in children and elderly

SARS-CoV-2 Antibody Kinetics in Unvaccinated Hospitalized Children With COVID-19

Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2

Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Children With Coronavirus Disease 2019, Multisystem Inflammatory Syndrome in Children, and After Two Doses of BNT162b2 Vaccination

Enhanced Airway Epithelial Response to SARS-CoV-2 Infection in Children is Critically Tuned by the Cross-Talk Between Immune and Epithelial Cells

Age-specific nasal epithelial responses to SARS-CoV-2 infection

Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19

Variant-specific antibody profiling for tracking SARS-CoV-2 variant infections in children and adolescents

Characteristics of innate, humoral and cellular immunity in children with non-severe SARS-CoV-2 infection

Delineating immune variation between adult and children COVID-19 cases and associations with disease severity

Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age

Preschool-age children maintain a distinct memory CD4 + T cell and memory B cell response after SARS-CoV-2 infection

Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children